Alnylam Pharmace. buy kyron7htx
Start price
05.02.19
/
50%
€76.96
Target price
07.02.19
€108.24
Performance (%)
-5.47%
End price
07.02.19
€72.75
Summary
This prediction ended on 07.02.19 with a price of €72.75. With a performance of -5.47%, the BUY prediction for Alnylam Pharmace. by kyron7htx closed slightly in the red. kyron7htx has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -1.097% | -1.097% | 23.600% | 43.292% |
| iShares Core DAX® | 1.280% | 1.320% | 13.605% | 15.782% |
| iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% | 38.434% |
| iShares Nikkei 225® | -2.006% | -1.389% | 8.973% | 6.570% |
| iShares S&P 500 | -0.662% | -1.884% | 23.684% | 39.611% |
Comments by kyron7htx for this prediction
In the thread Alnylam Pharmace. diskutieren
(Stop Loss Kurs erreicht)
Stopped prediction by kyron7htx for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€69.33
08.02.19
08.02.19
€108.24
04.11.21
04.11.21
116.51%
17.07.21
17.07.21
